🟢 Alvotech is trading 3.73% up today as XBI gains 2.55%

Alvotech is trading 3.73% up at ISK 668 as biotech shares strengthen broadly, with the XBI sector benchmark up 2.55%.

• No fresh company-specific announcement dated September 18, 2026, was identified.
• Alvotech’s official newsroom lists its latest relevant announcement as the August 31 FDA acceptance for AVT80.
• The move also follows optimism from Barclays’ September 16 upgrade, but that catalyst is not new today.